Rapid risk assessment: Risk of measles transmission in the EU/EEA
Risk of further spread and sustained transmission of measles in EU/EEA countries related to ongoing outbreaks and insufficient vaccination coverage.
Rapid risk assessment: Outbreak of yellow fever in Brazil, Third update.
In September 2017, the Ministry of Health in Brazil declared the end of the 2016–2017 yellow fever outbreak in the country. The upsurge of human cases since December 2017 and the continuous non-human primate epizootics since September 2017 indicate a continued or resumed increase in yellow fever virus circulation in Brazil. Since January 2018, most of the yellow fever cases have been reported from São Paulo, Rio de Janeiro and Minas Gerais states.
Guidelines for presentation of surveillance data
This document provides guidance to support epidemiologists and surveillance experts in producing tables, graphs and maps to show the results of their data analyses following harmonised principles and practices.
Rapid risk assessment: Outbreak of yellow fever in Brazil, Second update
This publication assesses the risk to EU/EEA countries and citizens associated with the ongoing outbreak of yellow fever in Brazil. This is the second update of a rapid risk assessment originally produced on 25 January 2017 and updated on 13 April 2017.
Joint Rapid Outbreak Assessment: Multi-country outbreak of Salmonella Agona infections linked to infant formula
This document provides an assessment of the public health risk associated with a multi-country outbreak of Salmonella Agona associated with consumption of potentially contaminated infant formula from France.
Multi-country outbreak of Salmonella Enteritidis infections linked to Polish eggs
This document provides an assessment of the public health risk associated with a multi-country outbreak of Salmonella Enteritidis, which is epidemiologically and microbiologically linked to contaminated eggs from Poland, and can be characterised by at least six MLVA profiles and four clusters defined by WGS (PHE SNP analysis).
Multi-country outbreak of Listeria monocytogenes PCR serogroup IVb, MLST ST6
A multi-country outbreak of Listeria monocytogenes PCR serogroup IVb, MLST ST6 has been ongoing in the EU/EEA since at least 2015.
Expert opinion on the introduction of the meningococcal B (4CMenB) vaccine in the EU/EEA
This expert opinion is intended to support national decision-making by summarising the considerations and concerns of some EU/EEA countries when they discussed whether to introduce the 4CMenB vaccine into their national immunisation programmes.
Expert opinion on meningococcal B vaccine – information and suggestions to EU/EEA countries
The ECDC expert opinion provides information on the burden of serogroup B invasive meningococcal disease in the EU/EEA, includes general considerations for 4CMenB introduction such as vaccine immunogenicity, safety, cost-effectiveness, ease of implementation and areas for country collaboration, and highlights different options for vaccine introduction.
Systematic review on active case finding of communicable diseases in prison settings
The objective of this report is to systematically review the evidence on active case finding in prison settings, with a focus on the European Union (EU) and the European Economic Area (EEA) region.